Literature DB >> 24447684

When does an enlarged cervical lymph node in a child need excision? A systematic review.

Richard Locke1, Rachael Comfort2, Haytham Kubba2.   

Abstract

BACKGROUND: Palpable cervical lymphadenopathy is very common in children. The clinician's job is to exclude malignancy as a cause and reach a diagnosis. In children selected for open biopsy, reactive hyperplasia and other inflammatory causes are far more common as a final diagnosis than malignancy. Furthermore complications can occur after open biopsy.
OBJECTIVE: To assess the diagnostic utility of clinical examination and investigations to exclude malignancy and other serious causes of paediatric cervical lymphadenopathy and minimise open biopsy. TYPE OF REVIEW: A systematic review of the literature with defined search strategy. SEARCH STRATEGY: A structured search of Medline, Embase, CINAHL and Cochrane databases. The references within standard paediatric ENT and head and neck textbooks were also examined.
RESULTS: The quality of evidence regarding predictors of malignancy is poor. Large lymph nodes and supraclavicular nodes are potential indicators of serious pathology. Fever, weight loss and organomegaly may be indicators but duration of symptoms and consistency are not. Abnormalities on chest X-ray are associated with serious causes but the diagnostic utility of routine chest X-ray is unknown. Ultrasound assessment of nodal architecture, margins, and shape (and possibly vascularity) shows considerable promise as a means of differentiating reactive hyperplasia from malignancy but further studies in children are required. Abnormalities in the full blood count (FBC) seem to be uncommon but when present are associated with serious causes of cervical lymphadenopathy, again the diagnostic utility is unclear. Serological testing may identify a specific cause and therefore avoid excision biopsy in around 10% of cases. Cutting needle biopsy requires further evaluation before it can be recommended. Fine needle aspiration cytology (FNAC) is very specific, but sensitivity varies in different studies to the extent that it cannot yet be relied upon to exclude malignancy.
CONCLUSIONS: Large and supraclavicular nodes should be biopsied. Ultrasound is likely to be useful but further study is required. FNAC cannot be relied upon to exclude malignancy in children. The diagnostic utility of chest X-ray and FBC are unclear. Work is required on multivariate predictive models.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cervical; Lymphadenopathy; Malignancy; Paediatric; Protocol

Mesh:

Year:  2013        PMID: 24447684     DOI: 10.1016/j.ijporl.2013.12.011

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  An approach to cervical lymphadenopathy in children.

Authors:  Serena Su Ying Chang; Mengfei Xiong; Choon How How; Dawn Meijuan Lee
Journal:  Singapore Med J       Date:  2020-11       Impact factor: 1.858

2.  Predictive factors for malignancy in patients with persistent cervical lymphadenopathy.

Authors:  Fatih Celenk; Secaattin Gulsen; Elif Baysal; Ismail Aytac; Seval Kul; Muzaffer Kanlikama
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-18       Impact factor: 2.503

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

4.  Clinical Characteristics of and Cancer Incidence in Children Evaluated for Lymphadenoapthy Referred to Pediatric Oncology Clinics.

Authors:  Sema Vural; Dildar Bahar Genc; Ezgi Celikboya
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-10-10

5.  Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC).

Authors:  Carson Wills; Katherine Mercer; Jozef Malysz; Lidys Rivera Galvis; Chandrika Gowda
Journal:  Children (Basel)       Date:  2022-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.